期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 51, 期 -, 页码 60-66出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2012.02.019
关键词
HIV-1; NNRTIs; Piperidine; Triazine; AIDS; SAR
资金
- National Natural Science Foundation of China (NSFC) [81102320, 30873133, 30772629, 30371686]
- NSFC for International Cooperation [30910103908]
- Research Fund for the Doctoral Program of Higher Education of China [20110131130005, 20110131120037, 070422083]
- Independent Innovation Foundation of Shandong University (IIFSDU) [2010GN044]
- Shandong Postdoctoral Innovation Science Research Special Program [201002023]
- China Postdoctoral Science Foundation [20100481282]
A novel series of piperidine-substituted triazine derivatives have been synthesized and evaluated for anti-HIV activities in MT-4 cells. Most compounds displayed extremely promising activity against wildtype HIV-1 with EC50 values in low nanomolar concentration, better than that of Nevirapine, Delavirdine, Zidovudine and Dideoxycitidine, and higher potency towards the resistant mutant strain K103N/Y181C than that of Nevirapine and Delavirdine. Selected compounds were also assayed against reverse transcriptase with lower IC50 values than that of Nevirapine. The structure-activity relationship (SAR) of these novel structural congeners was also discussed. (C) 2012 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据